ERIC DOBMEIER Insider Trading Transactions
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
Latest Insider Trading Transactions of ERIC DOBMEIER
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 800 | 4,200 | 4,598 | 3.8 K to 4.6 K (+21.06 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.62 | 1,100 | 12,782 | 3,798 | 4.9 K to 3.8 K (-22.46 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,100 | 5,775 | 4,898 | 3.8 K to 4.9 K (+28.96 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.61 | 900 | 10,449 | 3,798 | 4.7 K to 3.8 K (-19.16 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 900 | 4,725 | 4,698 | 3.8 K to 4.7 K (+23.70 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.60 | 1,200 | 13,920 | 3,798 | 5 K to 3.8 K (-24.01 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,200 | 6,300 | 4,998 | 3.8 K to 5 K (+31.60 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 1,400 | 16,226 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,400 | 7,350 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.58 | 400 | 4,632 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.57 | 1,100 | 12,727 | 3,798 | 4.9 K to 3.8 K (-22.46 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,100 | 5,775 | 4,898 | 3.8 K to 4.9 K (+28.96 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.56 | 600 | 6,936 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.54 | 282 | 3,254 | 3,798 | 4.1 K to 3.8 K (-6.91 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 282 | 1,481 | 4,080 | 3.8 K to 4.1 K (+7.42 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.53 | 500 | 5,765 | 3,798 | 4.3 K to 3.8 K (-11.63 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 500 | 2,625 | 4,298 | 3.8 K to 4.3 K (+13.16 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.52 | 500 | 5,760 | 3,798 | 4.3 K to 3.8 K (-11.63 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 500 | 2,625 | 4,298 | 3.8 K to 4.3 K (+13.16 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.51 | 518 | 5,962 | 3,798 | 4.3 K to 3.8 K (-12.00 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 518 | 2,720 | 4,316 | 3.8 K to 4.3 K (+13.64 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 4,700 | 54,050 | 3,798 | 8.5 K to 3.8 K (-55.31 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 4,700 | 24,675 | 8,498 | 3.8 K to 8.5 K (+123.75 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.60 | 1,300 | 15,080 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.73 | 400 | 4,692 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.72 | 100 | 1,172 | 3,798 | 3.9 K to 3.8 K (-2.57 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 100 | 525 | 3,898 | 3.8 K to 3.9 K (+2.63 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.71 | 300 | 3,513 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.70 | 1,300 | 15,210 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.69 | 600 | 7,014 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.68 | 3,480 | 40,646 | 3,798 | 7.3 K to 3.8 K (-47.82 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 3,480 | 18,270 | 7,278 | 3.8 K to 7.3 K (+91.63 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.67 | 1,300 | 15,171 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.66 | 2,220 | 25,885 | 3,798 | 6 K to 3.8 K (-36.89 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 2,220 | 11,655 | 6,018 | 3.8 K to 6 K (+58.45 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.65 | 1,400 | 16,310 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,400 | 7,350 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.64 | 1,800 | 20,952 | 3,798 | 5.6 K to 3.8 K (-32.15 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,800 | 9,450 | 5,598 | 3.8 K to 5.6 K (+47.39 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.61 | 400 | 4,644 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 183 | 2,121 | 3,798 | 4 K to 3.8 K (-4.60 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 183 | 961 | 3,981 | 3.8 K to 4 K (+4.82 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 717 | 8,310 | 3,798 | 4.5 K to 3.8 K (-15.88 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 717 | 3,635 | 4,515 | 3.8 K to 4.5 K (+18.88 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.58 | 4,200 | 48,636 | 3,798 | 8 K to 3.8 K (-52.51 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 4,200 | 21,294 | 7,998 | 3.8 K to 8 K (+110.58 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.57 | 3,180 | 36,793 | 3,798 | 7 K to 3.8 K (-45.57 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 3,180 | 16,123 | 6,978 | 3.8 K to 7 K (+83.73 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.56 | 3,600 | 41,616 | 3,798 | 7.4 K to 3.8 K (-48.66 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 3,600 | 18,252 | 7,398 | 3.8 K to 7.4 K (+94.79 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.55 | 1,620 | 18,711 | 3,798 | 5.4 K to 3.8 K (-29.90 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,620 | 8,213 | 5,418 | 3.8 K to 5.4 K (+42.65 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.54 | 1,000 | 11,540 | 3,798 | 4.8 K to 3.8 K (-20.84 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,000 | 5,070 | 4,798 | 3.8 K to 4.8 K (+26.33 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.53 | 1,000 | 11,530 | 3,798 | 4.8 K to 3.8 K (-20.84 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,000 | 5,070 | 4,798 | 3.8 K to 4.8 K (+26.33 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.52 | 2,000 | 23,040 | 3,798 | 5.8 K to 3.8 K (-34.49 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 2,000 | 10,140 | 5,798 | 3.8 K to 5.8 K (+52.66 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.51 | 1,400 | 16,114 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,400 | 7,098 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 1,900 | 21,850 | 3,798 | 5.7 K to 3.8 K (-33.35 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,900 | 9,633 | 5,698 | 3.8 K to 5.7 K (+50.03 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 20,000 | 230,000 | 3,798 | 23.8 K to 3.8 K (-84.04 %) |
Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 20,000 | 89,000 | 23,798 | 3.8 K to 23.8 K (+526.59 %) |
Aug 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.29 | 85,446 | 879,239 | 85,446 | |
Aug 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.29 | 4,554 | 46,861 | 4,554 | |
May 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.20 | 42,136 | 429,787 | 42,136 | |
May 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.20 | 7,864 | 80,213 | 7,864 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 11,470 | 60,218 | 59,383 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 700 | 3,675 | 70,853 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 4,135 | 21,709 | 71,553 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 4,300 | 22,575 | 75,688 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 3,496 | 18,354 | 79,988 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 3.30 | 3,400 | 11,220 | 0 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 3.30 | 5,556 | 18,335 | 3,400 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 2.77 | 7,711 | 21,359 | 0 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 2.77 | 2,704 | 7,490 | 7,711 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.90 | 3,400 | 30,260 | 1,798 | 5.2 K to 1.8 K (-65.41 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 3.30 | 3,400 | 11,220 | 5,198 | 1.8 K to 5.2 K (+189.10 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.91 | 5,556 | 49,504 | 1,798 | 7.4 K to 1.8 K (-75.55 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 3.30 | 5,556 | 18,335 | 7,354 | 1.8 K to 7.4 K (+309.01 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.91 | 7,711 | 68,705 | 1,798 | 9.5 K to 1.8 K (-81.09 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 2.70 | 7,711 | 20,820 | 9,509 | 1.8 K to 9.5 K (+428.87 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.92 | 2,704 | 24,120 | 1,798 | 4.5 K to 1.8 K (-60.06 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 2.77 | 2,704 | 7,490 | 4,502 | 1.8 K to 4.5 K (+150.39 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.92 | 11,470 | 102,312 | 1,798 | 13.3 K to 1.8 K (-86.45 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 11,470 | 60,218 | 13,268 | 1.8 K to 13.3 K (+637.93 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.93 | 700 | 6,251 | 1,798 | 2.5 K to 1.8 K (-28.02 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 700 | 3,675 | 2,498 | 1.8 K to 2.5 K (+38.93 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.95 | 4,135 | 37,008 | 1,798 | 5.9 K to 1.8 K (-69.69 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 4,135 | 21,709 | 5,933 | 1.8 K to 5.9 K (+229.98 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.98 | 4,300 | 38,614 | 1,798 | 6.1 K to 1.8 K (-70.51 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 4,300 | 22,575 | 6,098 | 1.8 K to 6.1 K (+239.15 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.99 | 3,496 | 31,429 | 1,798 | 5.3 K to 1.8 K (-66.04 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 3,496 | 18,354 | 5,294 | 1.8 K to 5.3 K (+194.44 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 9.00 | 6,328 | 56,952 | 1,798 | 8.1 K to 1.8 K (-77.87 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 9.00 | 200 | 1,800 | 8,126 | 8.3 K to 8.1 K (-2.40 %) |
Sep 08 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 4.45 | 62,618 | 278,650 | 62,618 | |
Sep 08 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 4.45 | 17,382 | 77,350 | 17,382 | |
Feb 01 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.63 | 38,281 | 215,522 | 38,281 | |
Feb 01 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.63 | 14,219 | 80,053 | 14,219 | |
Mar 03 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.07 | 46,351 | 235,000 | 46,351 | |
Mar 03 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.07 | 3,649 | 18,500 | 3,649 | |
Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 5.92 | 29,165 | 172,657 | 29,165 | |
Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 5.92 | 10,835 | 64,143 | 10,835 | |
Aug 24 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 6.74 | 20,461 | 137,907 | 20,461 | |
Aug 24 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 6.74 | 4,539 | 30,593 | 4,539 | |
Jun 22 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 61,516 | |
Jun 22 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 5.25 | 5,000 | 26,250 | 5,300 | 300 to 5.3 K (+1,666.67 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 3.30 | 2,500 | 8,250 | 13,123 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 3.30 | 3,127 | 10,319 | 15,623 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 4,373 | 12,113 | 10,415 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 2,500 | 6,925 | 14,788 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 2,500 | 6,925 | 17,288 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.70 | 2,500 | 21,750 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 3.30 | 2,500 | 8,250 | 2,800 | 300 to 2.8 K (+833.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.60 | 4,373 | 37,608 | 300 | 4.7 K to 300 (-93.58 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 4,373 | 12,113 | 4,673 | 300 to 4.7 K (+1,457.67 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.55 | 2,500 | 21,375 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 2,500 | 6,925 | 2,800 | 300 to 2.8 K (+833.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.60 | 3,127 | 26,892 | 300 | 3.4 K to 300 (-91.25 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 3.30 | 3,127 | 10,319 | 3,427 | 300 to 3.4 K (+1,042.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.50 | 2,500 | 21,250 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 2,500 | 6,925 | 2,800 | 300 to 2.8 K (+833.33 %) |
Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 10.33 | 18,229 | 188,306 | 18,229 | |
Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 10.33 | 6,771 | 69,944 | 6,771 | |
Sep 03 2003 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Vice President, | Option Exercise | A | 5.81 | 29,917 | 173,818 | 29,917 | |
Sep 03 2003 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Vice President, | Option Exercise | A | 5.81 | 10,083 | 58,582 | 10,083 |